Previous 10 | Next 10 |
home / stock / mkgaf / mkgaf news
The following slide deck was published by MERCK Kommanditgesellschaft auf Aktien in conjunction with their 2019 Q3 earnings Read more ...
MERCK Kommanditgesellschaft auf Aktien ( OTCPK:MKGAF ): Q3 Non-GAAP EPS of €1.35; GAAP EPS of €0.79. More news on: MERCK Kommanditgesellschaft auf Aktien, Earnings news and commentary, Healthcare stocks news, Read more ...
Introduction Better late than never. It`s update time, folks! I have used the last days with really bad weather here in Germany to research the last numbers and can now present you an update. Some users have already asked me about it – you can stop worry about me continueing my ar...
Merger activity decreased last week, with one new deal announced and seven deals closing. Deal Statistics: New Deals: The acquisition of Ra Pharmaceuticals ([[RARX]]) by UCB for $2.1 billion, or $48.00 per share in cash. Deal Updates: On October 8, 2019, Prosperity Bancs...
Up until recently, cannabis strains were divided into three distinct categories: indica, sativa, and hybrid. Indica use is reserved for pain relief, relaxation, and sleep; sativa is known for its uplifting, social, and creative properties; and hybrid strains fall somewhere in between depe...
Updated data from a Phase 1b/2 clinical trial, CLASSICAL-Lung , evaluating the combination of Vaccinex's (NASDAQ: VCNX ) lead candidate pepinemab and Pfizer (NYSE: PFE ) and Merck KGaA's ( OTCPK:MKGAF ) Bavencio (avelumab) in patients with treatment-resistant advanced non-small cel...
Merger activity remained unchanged last week with two new deals announced and seven deals closing. Deal Statistics: New Deals: The acquisition of Alder BioPharmaceuticals (ALDR) by H. Lundbeck A/S for $1.95 billion. Under the terms of the agreement, Alder stockholders will be of...
Novartis ( NVS ) announced that it had obtained Breakthrough Therapy Designation ((BTD)) for its drug capmatinib (INC280) to treat a specific subset of the NSCLC population. This program is in good shape, because the company is gearing up to file an NDA for approval for this drug in Q4 of ...
MERCK Kommanditgesellschaft auf Aktien (MKGAF) Q2 2019 Results Earnings Conference Call August 08, 2019, 08:00 AM ET Company Participants Constantin Fest - Head of Investor Relations Stefan Oschmann - CEO Marcus Kuhnert - Chief Financial Officer Conference Call Participants ...
The following slide deck was published by MERCK Kommanditgesellschaft auf Aktien in conjunction with their 2019 Q2 earnings Read more ...
News, Short Squeeze, Breakout and More Instantly...
Merck Kgaa Company Name:
MKGAF Stock Symbol:
OTCMKTS Market:
Bank of Georgia Group Plc (BDGSF) is expected to report for Q1 2024 iCad Inc. (ICAD) is expected to report for Q1 2024 Yasheng Group (HERB) is expected to report for Q1 2024 Bit Digital Inc. (BTBT) is expected to report $0.01 for Q1 2024 Estrella Immunopharma Inc. (ESLA) is expect...
Apartment Investment and Management Company (AIV) is expected to report for Q1 2024 Shopify Inc. Class A Subordinate (SHOP) is expected to report $0.08 for Q1 2024 Beyond Meat Inc. (BYND) is expected to report $-0.68 for Q1 2024 Instructure Holdings Inc. (INST) is expected to report $...
Gevo Inc. (GEVO) is expected to report $-0.05 for Q4 2023 Harvard Bioscience Inc. (HBIO) is expected to report $0.03 for Q4 2023 QuantaSing Group Limited (QSG) is expected to report $0.11 for Q2 2024 DFI Retail Group Holdings Limited ADR (DFIHY) is expected to report for quarter end 2...